In this webinar, panelists reviewed coverage and access issues that could negatively affect those with autoimmune diseases and conditions, the tenants of prior authorization and step therapy, discuss the role these policies can play in patient outcomes and on providers, and how current policies could be modified to better serve individuals.
The fiscal year (FY) 2023 omnibus spending legislation (H.R. 2617) includes all 12 FY2023 spending bills including resources for advancing women's health.
During this public forum, panelists discussed the disproportionate impact of autoimmune diseases and conditions on women and why tackling autoimmune diseases and conditions should be a federal priority. Following the discussion, panelists also reviewed SWHR’s newly launched autoimmune disease policy agenda.
Representatives Kathy Castor (D-FL), Brian Fitzpatrick (R-PA), and Lauren Underwood (D-IL) introduced H.R. 9487, the Advancing Safe Medications for Moms and Babies Act of 2022 on December 13, 2022.
The SWHR autoimmune policy agenda serves as a call to action for research, education, awareness, advocacy, clinical care, and coverage to support women impacted by autoimmune diseases and conditions.
It is estimated that between 23.5 million and 50 million Americans are living with autoimmune diseases and conditions, and the […]
With the impacts of gun violence felt across families, communities, and the country, it is not only a public health crisis but a women’s health issue.
The SWHR Alzheimer’s Policy Agenda was released in conjunction with Alzheimer’s Disease Awareness Month in November and serves as a resource for policymakers.
The Alzheimer’s Association estimates that there are 6.5 million adults age 65 and older who are living with Alzheimer’s disease […]